Abingdon Health (LON:ABDX) Trading Up 9.7% – Here’s What Happened

Shares of Abingdon Health Plc (LON:ABDX) were up 9.7% during mid-day trading on Tuesday . The company traded as high as GBX 8.50 ($0.11) and last traded at GBX 7.95 ($0.10). Approximately 435,852 shares were traded during mid-day trading, an increase of 101% from the average daily volume of 216,733 shares. The stock had previously closed at GBX 7.25 ($0.09).

Abingdon Health Trading Up 9.7 %

The firm has a fifty day moving average of GBX 7.90 and a 200 day moving average of GBX 9.36. The firm has a market capitalization of £15.07 million, a PE ratio of -899.00 and a beta of 0.13. The company has a debt-to-equity ratio of 46.64, a quick ratio of 1.96 and a current ratio of 1.95.

Abingdon Health Company Profile

Abingdon Health Plc engages in the development, manufacture, and distribution of diagnostic devices in the United Kingdom, the United States, Canada, Europe, and internationally. The company provides Abingdon Simply Test, a range of self-tests in the field of fertility, health and well-being, infectious diseases, and drug testing; PCRD and PCRD FLEX, are nucleic acid lateral flow tests, which are used for rapid readouts post isothermal amplification; and 2019-nCoV Antigen Test, a rapid lateral flow test for the qualitative detection of antigens to SARS-CoV-2, as well as plant health tests; and nucleic acid lateral flow immunoassays.